Board in Biological Technology

Marinus Pharmaceuticals Adds Two Life Sciences Veterans to its Board of Directors

BRANFORD, Conn., July 29 /PRNewswire/ -- Marinus Pharmaceuticals, Inc. a developer of drugs to treat serious neurological and psychiatric disorders, today announced the appointment of George F. Horner III of Sofinnova Ventures and Harry T. Rein of Foundation Medical Partners to its Board...

Signostics Closes Follow-On Financing of US$4 Million, Expands Board of Directors

PALO ALTO, Calif., July 21 /PRNewswire/ -- Signostics Inc., a U.S. and Australian-based medical device company developing groundbreaking personal ultrasound devices, announced today it has raised US$4 million in its latest round of financing, including new investments from Australian-bas...

Poniard Pharmaceuticals Appoints Gary A. Lyons to Board of Directors

SOUTH SAN FRANCISCO, Calif., July 9 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biopharmaceutical company focused on innovative oncology therapies, today announced the appointment of Gary A. Lyons, to the Company's board of directors. His appointment increases the...

IDEV Technologies Names Veteran Medical Device Executive Rick Anderson Chairman of the Board of Directors

HOUSTON, July 9 /PRNewswire/ -- IDEV Technologies, Incorporated, (IDEV) an emerging leader in the development and marketing of minimally invasive medical technologies, today announced the appointment of veteran medical device executive Rick Anderson to Chairman of its Board of Directors. Thomas M...

Mach One Corporation Begins Trading on the OTC Bulletin Board Under the Symbol 'MNCN'

BELGIUM, Wis., July 8 /PRNewswire-FirstCall/ -- Mach One Corporation (OTC Bulletin Board: MNCN), an innovative, global wellness solutions company, today announced that, effective immediately, its stock is trading on the OTC Bulletin Board under the symbol "MNCN." The Company's stock had previously...

Former Secretary of Veterans Affairs James Peake to Join the Cellphire Board of Directors

Peake to provide guidance and direction regarding military needs, clinical uses and funding sources ROCKVILLE, Md., June 30 /PRNewswire/ -- Cellphire, Inc., a biotechnology company located in Rockville, Md., announced today that former Secretary of the Department of Veterans Affairs, James Pe...

Rib-X Pharmaceuticals, Inc. Appoints Dr. Russell Greig to Board of Directors

NEW HAVEN, Conn., June 30 /PRNewswire/ -- Rib-X Pharmaceuticals, Inc., a development stage company focused on the discovery and development of novel antibiotics for the treatment of antibiotic resistant infections, announced today that Russell Greig, Ph.D., of SR One venture capital, has been appo...

Novavax Appoints Stanley Erck to Board of Directors

ROCKVILLE, Md., June 26 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX ) announced today the appointment of Stanley Erck to the company's Board of Directors. Mr. Erck has more than twenty five years of experience in the biotechnology and health-care industries and served most recently as...

Paulo F. Costa Joins MacroGenics Board of Directors

ROCKVILLE, Md., June 23 /PRNewswire/ -- MacroGenics, Inc. announced today that Mr. Paulo F. Costa has been elected to the company's Board as an independent director. Mr. Costa is the former President and Chief Executive Officer of Novartis U.S. Corporation. With more than 35 years of experience ...

Martin Madaus Joins Mettler Toledo Board of Directors

COLUMBUS, Ohio, June 22 /PRNewswire-FirstCall/ -- Mettler-Toledo International Inc. (NYSE: MTD ) announced today that Dr. Martin D. Madaus has been appointed to its Board of Directors, effective July 1, 2009. Dr. Madaus is Chairman, President and Chief Executive Officer of Millipore Corpora...

iZumi Bio Appoints Dr. Corey Goodman to Board of Directors and Scientific Advisory Board

SOUTH SAN FRANCISCO, Calif., June 11 /PRNewswire/ -- iZumi Bio, Inc., a biopharmaceutical company focused on the industrialization of induced pluripotent stem cell (iPS) technology with the mission of creating new therapeutics through cellular reprogramming and directed differentiation of patient ...

Techne Corporation Board Member Recognized

MINNEAPOLIS, June 10 /PRNewswire-FirstCall/ -- Charles A. Dinarello, M.D., a Professor of Medicine at the University of Colorado School of Medicine in Denver and a member of the Techne Corporation Board of Directors, was recently recognized with two distinguished awards. On April 26, 2009, D...

NeoStem, Inc. Appoints Financial Expert with Broad International Experience to the Board of Directors and to Serve as Chairman of the Company's Audit Committee

NEW YORK, June 10 /PRNewswire/ -- NeoStem, Inc. (NYSE Amex: NBS ), which is pioneering the pre-disease collection, processing and long-term storage of adult stem cells for future medical need, announced today it has appointed to its Board of Directors Drew Bernstein, CPA and Managing Partner of ...

Senesco Technologies, Inc. Announces the Appointment of Dr. Harlan W. Waksal, M.D. as Chairman of the Board of Directors and the Addition of Mr. Warren J. Isabelle, CFA to its Board of Directors

NEW BRUNSWICK, N.J., June 9 /PRNewswire-FirstCall/ -- Senesco Technologies, Inc. ("Senesco" or the "Company") (NYSE Amex: SNT ) today announced the appointment, effective June 8, 2009, of its current Board member, Dr. Harlan Waksal, M.D., to serve as Chairman of the Board, succeeding Mr. Rudol...

Sirius Genomics Announces 2009 Board of Directors

VANCOUVER, June 8 /PRNewswire/ - Sirius Genomics, a developer of pharmacogenomic diagnostics, announced that it has elected its 2009 Board of Directors at its recent Annual General Meeting. The six-member Board consists of: Dr. James McEwen (Chairman), Dr. Heiner Dreismann, Mr. Jim Heppell, Mr. Am...

Icahn Indicates That Biogen Board Refuses To Close Polls

NEW YORK, June 3 /PRNewswire/ -- Carl Icahn announced today that Biogen is acting in its usual shareholder unfriendly way by manipulating the annual meeting of shareholders in order the prevent the votes that have been submitted from being counted. They are doing so in order to attempt to keep tw...

TorreyPines Therapeutics Announces its Board of Directors' Approval of Plan of Liquidation and Dissolution

LA JOLLA, Calif., May 29 /PRNewswire/ -- TorreyPines Therapeutics, Inc. (Nasdaq: TPTX ) today announced that its Board of Directors has determined, after consideration of potential strategic and financing alternatives, that it is in the best interests of the Company and its stockholders to liqui...

Transgenomic, Inc. Announces Appointment of New Board Members

OMAHA, Neb., May 22 /PRNewswire-FirstCall/ -- Transgenomic, Inc. (OTC Bulletin Board: TBIO) announces that it has appointed Antonius P. Schuh, Ph.D. and Michael B. McNulty to its Board of Directors. Dr. Schuh is the Founding Chairman and Chief Executive Officer of Sorrento Therapeutics, Inc. ...

Techne Corporation Announces the Retirement of G. Arthur Herbert, a Member of Its Board of Directors

MINNEAPOLIS, May 19 /PRNewswire-FirstCall/ -- G. Arthur Herbert, a Techne Corporation (Nasdaq: TECH ) Director and member of its Audit Committee, Executive Compensation Committee and Nomination and Governance Committee, announced today that he is planning to retire at the end of his current term...

Arpida Annual General Meeting of Shareholders Approves All Board Proposals

REINACH, Switzerland, May 7 /PRNewswire-FirstCall/ -- The Annual General Meeting of Arpida Ltd (SIX: ARPN) has approved the proposals that were put forward by the Board of Directors. A total of 90 shareholders were present at the meeting that took place in Reinach today. 4,629,711 share...

Andre Marion Joins Microchip Biotechnologies' Board of Directors

DUBLIN, Calif., May 7 /PRNewswire/ -- Microchip Biotechnologies, a private company developing the Apollo next-generation fluidics platform for life sciences, announced today that Andre F. Marion has accepted a board position to its Board of Directors, effective immediately. Mr. Marion was former C...

Covance Elects John McCartney to Company's Board of Directors

PRINCETON, N.J., May 7 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD ) announced that it has elected John McCartney to its board of directors. Mr. McCartney currently serves as chairman of the board of A.M. Castle Corporation, a provider of specialty products, services, and supply chai...

Richard Giltner Joins United Therapeutics Board of Directors

SILVER SPRING, Md., April 29 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR ) announced today the appointment of Mr. Richard Giltner to its Board of Directors as an independent director. Mr. Giltner has over twenty years of experience in the financial sector. His ...

Concerned Shareholders of Biovail Announce - Independent Nominees for Election to Biovail Board of Directors - A Focused Commitment to Governance at Biovail

TORONTO, April 27 /PRNewswire/ - In connection with the requisition of Mr. Eugene Melnyk and EM Holdings B.V. (the "Concerned Shareholders") relating to the annual and special meeting of shareholders of Biovail Corporation ("Biovail") to be held on May 28, 2009 (the "Meeting"), the Concerned Share...

The Advisory Board Company Schedules Fourth Quarter Conference Call for May 5, 2009

WASHINGTON , April 24 /PRNewswire-FirstCall/ -- The Advisory Board Company (Nasdaq: ABCO ) announced today that it will hold a conference call hosted by Robert W. Musslewhite, Chief Executive Officer and Director, and Michael T. Kirshbaum, Chief Financial Officer, to discuss the Company's finan...

Pharmalink AB Strengthens its Board of Directors and Signals a Strategic Step Towards Late Phase Product Development

STOCKHOLM, April 23 /PRNewswire/ -- Pharmalink AB today announced that it has strengthened its Board of Directors as the company's portfolio continues to move towards late stage product development and commercialization. Two highly experienced pharmaceutical and biotechnology advisors, Anders ...

Metabolex Announces Election of Kurt von Emster to Board of Directors

HAYWARD, Calif., April 22 /PRNewswire/ -- Metabolex, Inc., a biopharmaceutical company focused on the discovery and development of proprietary new therapeutics for the treatment of diabetes and related metabolic disorders, announced that Kurt von Emster has been elected to its Board of Directo...

Angela Shen-Hsieh of Visual I|O Named to Board of Directors of AIGA: Oldest and Largest Membership Organization for Designers

Angela Shen-Hsieh, Founder of Visual I|O has been named to the Board of Directors of AIGA--the oldest and largest membership organization for designers. Visual I|O provides enterprise class business intelligence software, that lets users throughout an organization to interact dynamically and vis...

NexBio Completes Clinical Advisory Board for the Advanced Development of DAS181 (Fludase(R)*), a First-In-Class Medicine for Influenza

SAN DIEGO, April 15 /PRNewswire/ -- NexBio, Inc. announced today that it has completed the formation of a new Clinical Advisory Board (CAB) to complement its existing group of Senior Advisers. NexBio recently completed a First-In-Man clinical trial of DAS181 (Fludase(R)), an investigational d...

Stemedica Signs Scientific Advisory Board Agreement with Leading Pediatric Burn & Wound Care Researcher

Stemedica Cell Technologies, Inc., a leader in adult stem cell research and manufacturing, announced that Lee Ann Laurent-Applegate PD & MER has joined Stemedica's Scientific Advisory Board. In this capacity, she will help Stemedica advance the clinical development of a proprietary whole cel...

New Pharmaxis Board Appointment

SYDNEY, April 6 /PRNewswire-Asia/ -- Pharmaceutical company Pharmaxis (ASX: PXS; Nasdaq: PXSL ) today announced the appointment of the U.S. life science investment manager Richard van den Broek to its Board of Directors. Mr van den Broek is founder and managing partner of HSMR Advisor...

Xmark Requests That Icagen Oust Its CEO and Pursue Strategic Alternatives, and Calls on Board Members to Resign

RIDGEFIELD, Conn., April 1 /PRNewswire/ -- On April 1, 2009, Xmark Opportunity Partners, LLC, the sole member of the investment manager of Xmark Opportunity Fund, L.P. and Xmark Opportunity Fund, Ltd., sent the following letter to the Board of Directors of Icagen, Inc. (Nasdaq: ICGN ). ...

Fina Technologies Names Spotfire Founder Christopher Ahlberg to Board of Directors

CAMBRIDGE, Mass., March 31 /PRNewswire/ -- Fina Technologies, Inc. today announced that it named Dr. Christopher Ahlberg, a pioneering entrepreneur and scientist, and founder of Spotfire, Inc., to its Board of Directors. Dr. Ahlberg most previously was Executive Vice President, Tibco, Inc.,...

Endo Pharmaceuticals Appoints Dr. Nancy Hutson to Board of Directors

CHADDS FORD, Pa., March 30 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP ) announced today the appointment of Nancy J. Hutson, Ph.D., to the company's board of directors. Dr. Hutson retired from Pfizer, Inc. in 2006 after spending 25 years in various research and leadership posit...

Allegro Diagnostics Expands Board and Executive Team

Allegro Diagnostics, a leader in the field of molecular diagnostics for lung cancer, has announced that Stephen Chubb has joined the company's board of directors and Stephanie Hallam, Ph.D. has joined the company as Vice President of Operations and Quality Systems. Bost...

Biotechnology Value Fund, L.P. Announces Overwhelming Support to Remove the Board of Directors of Avigen, Inc. at Special Meeting of Stockholders

Concurs with Avigen's decision to return capital to stockholders through liquidation A decisive victory for stockholder democracy SAN FRANCISCO, March 27 /PRNewswire/ -- Biotechnology Value Fund, L.P. ("BVF"), today announced that stockholders of Avigen (Nasdaq: AVGN ) voted overwhelmi...

Novexel Strengthens its Scientific Advisory Board With the Appointment of Dr. Karen Bush

PARIS, March 26 /PRNewswire-FirstCall/ -- Novexel, a speciality pharmaceutical company focused on the discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance, announces today the appointment of Dr. Karen Bush to the Company's S...

Dr. Thomas Werner Elected to Accera, Inc.'s Board of Directors

BROOMFIELD, Colo., March 24 /PRNewswire/ -- Accera, Inc., a biotechnology company delivering breakthrough therapies in central nervous system (CNS) diseases, announced today that Thomas Werner, Ph.D. has been elected to its board of directors. Since 2001, Dr. Werner has been a managing direct...

Catalyst Biosciences Expands Scientific Advisory Board With Leading Experts in Protease Therapeutic Discovery and Development

SOUTH SAN FRANCISCO, Calif., March 24 /PRNewswire/ -- Catalyst Biosciences, Inc., a pioneer in the discovery and development of engineered proteases known as Alterase(TM) therapeutics, has appointed four new members to the company's Scientific Advisory Board (SAB). Robert J. Fletterick, Ph.D., Da...

Joseph Loscalzo, M.D., PhD. to Join N30 Pharma Board and Chair Scientific Advisory Board

BOULDER, Colo., March 23 /PRNewswire/ -- N30 Pharma (N30) today announced that Joseph Loscalzo, M.D., PhD., has joined the Board of Directors of the Company. Dr. Loscalzo currently serves as Hersey Professor of the Theory and Practice of Medicine at Harvard , Physician-in-Chief at Brigham an...